Capricor Therapeutics Inc Earnings

The next earnings date for Capricor Therapeutics Inc has not yet been scheduled.

Analyst Estimates of Capricor Therapeutics Inc Earnings

No Results.
Report DateEstimated Earnings Per Share
No Results.

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Capricor Therapeutics Inc Earnings: Historical

Report DateBefore/After MarketEarnings Per ShareSurprise %
11/12/2025---$-0.54-14.41%
08/07/2025---$0100.00%
05/12/2025Before Market$-0.53-66.67%
02/26/2025Before Market------
11/12/2024Before Market$-0.38-5.56%
08/07/2024After Market$-0.352.78%
05/13/2024After Market$-0.31-181.82%
02/29/2024After Market$-0.0277.78%
11/14/2023After Market$-0.2513.79%
08/07/2023After Market$-0.2917.14%
05/11/2023After Market$-0.313.13%
03/15/2023After Market$-0.316.06%
11/10/2022After Market$-0.2610.34%
08/10/2022After Market$-0.29-16.00%
05/10/2022After Market$-0.32---
03/10/2022After Market$-0.26-36.84%
11/09/2021After Market$-0.1722.73%
08/12/2021After Market$-0.218.70%
05/13/2021After Market$-0.23---
03/11/2021After Market$-0.21-5.00%
11/12/2020After Market$-0.20-11.11%
08/06/2020After Market$-0.2337.84%
05/14/2020After Market$-0.309.09%
03/18/2020After Market$-0.340.00%
11/07/2019After Market$-0.4338.57%
08/06/2019After Market$-0.5926.25%
05/13/2019After Market$-0.8027.27%
03/28/2019After Market$-1.1031.25%
11/13/2018After Market$-1.403.45%
08/09/2018After Market$-1.40-12.00%
05/10/2018After Market$-1.40-16.67%
03/14/2018After Market$-1.10-10.00%
11/08/2017After Market$-1.2036.84%
08/10/2017After Market$-1.6011.11%
05/15/2017After Market$-1.70-13.33%
03/15/2017After Market$-1.4053.33%
11/10/2016After Market$-2.90-9.43%
08/15/2016After Market$-2.60-8.33%
05/12/2016After Market$-2.60-36.84%
03/17/2016After Market$-2.10-10.53%
11/12/2015After Market$-1.8030.77%
08/13/2015After Market$-1.9026.92%
05/12/2015After Market$-2.30-64.29%
03/16/2015After Market$-1.60-23.08%
11/14/2014Before Market$-1.3040.91%
08/14/2014After Market$-1.31---
05/15/2014---$-1.04---
03/17/2014---$-6.39---
11/15/2013---$-4.02---
08/15/2013---$-6.94---
06/21/2013---$-5.61---
03/12/2013---$-2.39---
11/12/2012---$-6.57---
08/13/2012---$-4.11---
05/15/2012---$-20-33.33%
03/13/2012---$-22.29---
11/14/2011---$-15-100.00%
08/15/2011---$-15-200.00%
05/16/2011---$-15-50.00%
03/14/2011---$-1053.85%
11/12/2010---$-25-7.16%
08/16/2010---$-2524.99%
05/14/2010---$-35-23.54%
03/03/2010---$-30-20.00%
11/12/2009---$-40-60.00%
08/13/2009---$-50-33.33%
05/14/2009---$-3540.00%
03/09/2009---$-607.69%
11/13/2008---$-7010.63%
08/14/2008---$-80-39.13%
05/15/2008---$-65-18.18%
03/13/2008---$-5047.37%
11/28/2007---$-173.63---
12/31/2006---$-6.69---
09/30/2006---$-23.16---
06/30/2006---$-5.98---
03/31/2006---$-4.79---
09/30/2005---$-2.28---
06/30/2005---$-1.95---
03/31/2005---$-3.57---
12/31/2004---$-6.14---
09/30/2004---$-2.33---
06/30/2004---$-1.90---
03/31/2004---$-1.64---
12/31/2003---$-3.57---
09/30/2003---$-0.06---
06/30/2003---$-4.61---
03/31/2003---$-2.46---
12/31/2002---$-2.50---
09/30/2002---$-5.67---
06/30/2002---$-6.25---

More About Capricor Therapeutics Inc

Website
https://www.capricor.com
Country
USA
Full Time Employees
160

Capricor Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based therapeutics for treating duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs in the United States. Its lead product candidate is the Deramiocel, an allogeneic cardiosphere-derived cells, which is in phase 3 clinical trial for the treatment of DMD. The company also develops Exosome protein-based vaccine, which is in preclinical trial to treat SARS-CoV-2; StealthX Exosome Platform, and exosome platform program consists of engineered exosomes for vaccine and therapeutic development and is in preclinical trial. In addition, it engages in developing StealthX, an engineered exosome-based vaccine candidate, under phase 1 clinical study for a range of therapeutic applications, including targeted RNA, protein, and small molecule therapeutics to treat or prevent a variety of diseases; and CAP-2003, and allogeneic cardiosphere-derived cells-exosomes, which is in preclinical trial to treat DMD. It has license agreement with Johns Hopkins University, University of Rome License, and Cedars-Sinai Medical Center to develop and commercialize licensed products and licensed services under the licensed patent rights in all fields and a nonexclusive right to the know-how; Cell Line License Agreement with Life Technologies for the development of exosomes platform. The company was founded in 2005 and is headquartered in San Diego, California.

“Capricor Therapeutics Inc Earnings” Can Refer to the Capricor Therapeutics Inc Earnings Date

Some people say “Capricor Therapeutics Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Capricor Therapeutics Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Capricor Therapeutics Inc Stock on the Earnings Date

If you own Capricor Therapeutics Inc stock (CAPR) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Capricor Therapeutics Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Capricor Therapeutics Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Capricor Therapeutics Inc Earnings

You can contact us any time if you would like to ask questions about Capricor Therapeutics Inc earnings or anything else related to the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.